Executive officer

Alok Sonig

Executive Vice President & Group President, Pharmaceuticals·Baxter International Inc.

About

A

l

o

k

S

o

n

i

g

s

e

r

v

e

d

a

s

E

x

e

c

u

t

i

v

e

V

i

c

e

P

r

e

s

i

d

e

n

t

a

n

d

G

r

o

u

p

P

r

e

s

i

d

e

n

t

,

P

h

a

r

m

a

c

e

u

t

i

c

a

l

s

o

f

B

a

x

t

e

r

I

n

t

e

r

n

a

t

i

o

n

a

l

.

O

n

N

o

v

e

m

b

e

r

5

,

2

0

2

5

,

h

e

n

o

t

i

f

i

e

d

t

h

e

c

o

m

p

a

n

y

o

f

h

i

s

d

e

c

i

s

i

o

n

t

o

r

e

s

i

g

n

f

r

o

m

t

h

a

t

r

o

l

e

,

e

f

f

e

c

t

i

v

e

D

e

c

e

m

b

e

r

1

,

2

0

2

5

,

t

o

j

o

i

n

a

c

o

m

p

a

n

y

i

n

t

h

e

h

e

a

l

t

h

c

a

r

e

i

n

d

u

s

t

r

y

.

Also at Baxter International Inc.

AH Andrew P. Hider President & CEO BS Brent Shafer Non-Executive Chair of the Board WI William A. Ampofo II Director JC Jeffrey A. Craig Director MM Michael R. McDonnell Director PM Patricia B. Morrison Director

Roles

Organization Role Dates Details
Baxter International Inc. Executive Vice President & Group President, Pharmaceuticals Present Current role
Baxter International Inc. Executive Vice President and Group President, Pharmaceuticals until December 1, 2025 Notified the company of his resignation on November 5, 2025.
Lupin, Inc. US CEO and Global Head of R&D and Biosimilars
Dr. Reddy's Laboratories CEO of Developed Markets
Bristol Myers Squibb General management, global strategy and marketing roles 15+ years

Related

Source: Baxter International Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo